Methyl 2-[2-(2,6-dichlorophenyl)-N-methylacetamido]acetate

Catalog No.: 
ACPNMQ389
CAS No.: 
1153115-13-9
Molecular Formula: 
C12H13Cl2NO3
Molecular Weight: 
290.15
Methyl 2-[2-(2,6-dichlorophenyl)-N-methylacetamido]acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00InquiryInquiry
100mg95%$100.00InquiryInquiry
250mg95%$132.00InquiryInquiry
5g95%$943.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-[2-(2,6-dichlorophenyl)-N-methylacetamido]acetate
IUPAC Namemethyl N-(2-(2,6-dichlorophenyl)acetyl)-N-methylglycinate
MDL No.MFCD12643619
Molecular FormulaC12H13Cl2NO3
Molecular Weight290.15
SMILESO=C(OC)CN(C)C(CC1=C(Cl)C=CC=C1Cl)=O
InChI KeyLGBOFWZQOIRSJS-UHFFFAOYSA-N
Synonymmethyl 2-[2-(2,6-dichlorophenyl)-N-methylacetamido]acetate;Glycine, N-[2-(2,6-dichlorophenyl)acetyl]-N-methyl-, methyl ester
CAS No.1153115-13-9

Synthetic Route by SureRoute

1. ACPNMQ389 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQGVW058 route compound structure diagram
    ACQGVW05813515-93-0In Stock
  2. Plus
  3. ACSRMT492 route compound structure diagram
    ACSRMT4926575-24-2In Stock
  4. Then
  5. ACPNMQ389 route product structure diagram
    ACPNMQ3891153115-13-9
Inquiry

2. ACPNMQ389 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQGVW058 route compound structure diagram
    ACQGVW05813515-93-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPNMQ389 route product structure diagram
    ACPNMQ3891153115-13-9
Inquiry

3. ACPNMQ389 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPNMQ389 route product structure diagram
    ACPNMQ3891153115-13-9
Inquiry

Comments (0)